Board okays share swap allotment of 1.61 crore shares at Rs 48.20

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Next day

₹143.90

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.3% vs market

Computers - Software & Consulting peers, median of 67sector-1.3%+1.3% vs sector

By the next day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-1.3—-0.9—

Next day

+0.0-1.3+1.3-1.3+1.3

+0.0+0.0-0.0-0.7+0.7

—-0.2—-0.7—

+0.0-3.0+3.0-2.9+2.9

—-2.7—-1.5—

+0.0-1.7+1.7-0.1+0.1

15d

+0.0-8.9+8.9-4.1+4.1

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 67Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

iSera Lifesciences Board approved allotment of 1.61 crore equity shares at Rs 48.20 each via share swap with iSera Biological Limited shareholders at a 1:1 ratio. Non-cash preferential issue. Post-allotment paid-up capital rises to 2.45 crore shares from 84.08 lakh. 196 allottees include promoters, Nav Capital VCC, M7 Global Fund and celebrities like Jasprit Bumrah, Aamir Khan, Ranbir Kapoor.

Likely market impact

Share count rises nearly threefold via non-cash swap. Existing shareholders get diluted; new investors enter the cap table through the acquisition route.